ST. LOUIS, Feb. 16, 2011 /PRNewswire/ --
Sigma-Aldrich® Corporation (Nasdaq: SIAL) announces the following
executive leadership appointments intended to more closely align
its corporate structure with its strategic plan.
Frank Wicks, President Research,
will assume responsibility for the entire portfolio of Research
products, including those in Research Essentials, Research
Specialties and Research Biotech. This newly combined
Research strategic business unit will be responsible for product
development and R&D; strategic marketing and branding; and
global sourcing and operations strategies. This new
organization will better enable the Company to accelerate strategic
initiatives in defined key areas of focus: Analytical, Biology and
Chemistry with an added emphasis on the fast growing materials
science market. Wicks will continue to report to the CEO,
Rakesh Sachdev.
David Smoller, formerly President
Research Biotech, has been appointed Chief Scientific Officer
reporting to Frank Wicks. In this
new role, Smoller will be responsible for developing a global
R&D strategy and footprint for all research and development
initiatives as well as managing our intellectual property portfolio
and licensing activity. He will continue to be responsible
for developing and commercializing innovative products in emerging
technologies of Biology and will leverage his successes in bringing
new technologies to market in the area of materials science.
Gerrit van den Dool has been
promoted to Vice President and Managing Director US and Canada
Region. He will have responsibility for the execution of our
Research business strategy as well as supporting the SAFC business
in US/Canada including sales,
service, distribution, manufacturing and compliance. Prior to
relocating from Germany to the US
in 2007 to head-up North America
sales and Global Accounts, van den
Dool successfully led European Sales and Operations.
Mike Harris and Eric Green
will continue as Vice Presidents and Managing Directors of the
Europe, Middle East, Africa (EMEA) and International regions,
respectively, and, with van den
Dool, will report to the CEO.
Gilles Cottier, President SAFC,
will continue to lead the global SAFC organization and report to
the CEO. Cottier and his team are responsible for developing and
executing the global strategies to enhance the bio-science, custom
Pharma, high-tech and supply solutions businesses.
Rakesh Sachdev, President and
CEO, stated, "We expect this new organization to significantly
enhance the organic growth of our core Research and SAFC
businesses. This proven leadership team is best situated to
execute the key legs of our growth strategy while driving
operational excellence and deploying our financial strength to
boost growth through acquisitions."
About Sigma-Aldrich: Sigma-Aldrich is a leading Life
Science and High Technology company. Our
biochemical and organic chemical products and kits are used in
scientific research, including genomic and proteomic research,
biotechnology, pharmaceutical development, and as key components in
pharmaceutical, diagnostic and other high technology manufacturing.
We have customers in life science companies, university and
government institutions, hospitals and in industry. Over one
million scientists and technologists use our products.
Sigma-Aldrich operates in 40 countries and has 7,900
employees providing excellent service worldwide. We are
committed to accelerating our Customers' success through leadership
in Life Science, High Technology and
Service. For more information about
Sigma-Aldrich, please visit our award winning web site at
www.sigma-aldrich.com.
SOURCE Sigma-Aldrich Corporation